• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Patient Case #1: Inflammation management in a 68-year-old patient following routine cataract surgery


Denise Visco, MD, MBA, reviews Inflammation management in a 68-year-old patient following routine cataract surgery.

Denise Visco, MD, MBA: Hello, I’m Dr Denise Visco, an ocular surgeon and medical director at Eyes of York Cataract and Laser Center in York, Pennsylvania. I’m excited to share 2 cataract cases we discussed in a recent ophthalmology times roundtable.

Our first case of the program was a 68-year-old who presented for routine cataract surgery. Their ocular examination was unremarkable, except for the cataracts, and the patient did have a past medical history of diabetes mellitus without any evidence of diabetic retinopathy. There was no vitreomacular traction, and the examination was typical for what we find with routine cataract surgery in all of our practices around the world. The question was posed, what is the initial impression of the case and what challenge is present with our routine cataract surgery patients in managing their pain and inflammation perioperatively.

When the initial impression of the case, despite being routine [was posed to] the group, [they] had several concerns. First, as a diabetic, there could potentially be issues with wound healing, and the patient would be considered at higher risk for CME [cystoid macular edema]. We know that our routine cataract surgery cases have a 25% risk of unexpected pupillary meiosis with cataract surgery. And, the typical concern about infection was also stated as a potential challenge with this patient.


Related Videos
Vance Thompson, MD
© 2024 MJH Life Sciences

All rights reserved.